Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 6.16% is 16% below its 5-year average of 7.30%, around the middle of its 5-year range (0.64%–11.57%).
As of the fiscal period ended Tuesday, June 30, 2026. 63.79% above its 12-month average of 3.76%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
6.16%
RETURN ON EQUITY (ROE) AVG TTM
3.76%
RETURN ON EQUITY (ROE) AVG 3Y
6.50%
RETURN ON EQUITY (ROE) AVG 5Y
7.30%
RETURN ON EQUITY (ROE) AVG 10Y
9.06%
RETURN ON EQUITY (ROE) AVG 15Y
10.02%
RETURN ON EQUITY (ROE) AVG 20Y
10.17%
CURRENT VS TTM AVG
+63.79%
CURRENT VS 3Y AVG
-5.26%
CURRENT VS 5Y AVG
-15.66%
CURRENT VS 10Y AVG
-32.06%
CURRENT VS 15Y AVG
-38.59%
CURRENT VS 20Y AVG
-39.46%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
-52.69%
vs the sector median at left
CVS Health Corp.
Market Cap
$122.13B
Return on Equity (ROE)
6.16%
TTM Avg
3.76%
3Y Avg
6.50%
5Y Avg
7.30%
Market Cap
$124.07B
Return on Equity (ROE)
17.28%
TTM Avg
15.07%
3Y Avg
13.91%
5Y Avg
13.46%
Market Cap
$118.24B
Return on Equity (ROE)
10.41%
TTM Avg
9.71%
3Y Avg
8.51%
5Y Avg
8.44%
Market Cap
$131.96B
Return on Equity (ROE)
41.59%
TTM Avg
-8.30%
3Y Avg
7.76%
5Y Avg
4.45%
Market Cap
$132.36B
Return on Equity (ROE)
21.76%
TTM Avg
8.96%
3Y Avg
15.60%
5Y Avg
19.47%
Market Cap
$105.00B
Return on Equity (ROE)
15.55%
TTM Avg
14.50%
3Y Avg
15.05%
5Y Avg
14.30%
Market Cap
$104.77B
Return on Equity (ROE)
N/A
TTM Avg
-189.06%
3Y Avg
-180.53%
5Y Avg
3473.86%
Market Cap
$144.17B
Return on Equity (ROE)
7.61%
TTM Avg
7.38%
3Y Avg
9.51%
5Y Avg
10.24%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CVS Health Corp. (CVS) | $122.13B | 6.16% | 3.76% | 6.50% | 7.30% |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.07B | 17.28% | 15.07% | 13.91% | 13.46% |
| Medtronic plc (MDT)vs › | $118.24B | 10.41% | 9.71% | 8.51% | 8.44% |
| Bristol-Myers Squibb Company (BMY)vs › | $131.96B | 41.59% | -8.30% | 7.76% | 4.45% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $132.36B | 21.76% | 8.96% | 15.60% | 19.47% |
| Stryker Corporation (SYK)vs › | $105.00B | 15.55% | 14.50% | 15.05% | 14.30% |
| McKesson Corporation (MCK)vs › | $104.77B | N/A | -189.06% | -180.53% | 3473.86% |
| Sanofi (SNY)vs › | $103.24B | 5.82% | 9.06% | 9.15% | 10.86% |
| Danaher Corporation (DHR)vs › | $144.17B | 7.61% | 7.38% | 9.51% | 10.24% |
| GSK plc (GSK)vs › | $97.83B | 27.67% | 26.90% | 55.97% | 45.70% |
ROE
6.2%
ROA
1.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 6.16% |
| 2026-03-31 | 3.79% |
| 2025-12-31 | 2.35% |
| 2025-09-30 | 0.64% |
| 2025-06-30 | 5.86% |
| 2025-03-31 | 6.86% |
| 2024-12-31 | 6.11% |
| 2024-09-30 | 6.69% |
| 2024-06-30 | 9.60% |
| 2024-03-31 | 9.90% |
| 2023-12-31 | 10.91% |
| 2023-09-30 | 11.57% |
| 2023-06-30 | 4.03% |
| 2023-03-31 | 5.69% |
| 2022-12-31 | 5.99% |
| 2022-09-30 | 4.64% |
| 2022-06-30 | 11.02% |
| 2022-03-31 | 10.89% |
| 2021-12-31 | 10.54% |
| 2021-09-30 | 10.20% |
| 2021-06-30 | 9.83% |
| 2021-03-31 | 10.44% |
| 2020-12-31 | 10.35% |
| 2020-09-30 | 11.56% |
| 2020-06-30 | 12.14% |
| 2020-03-31 | 11.08% |
| 2019-12-31 | 10.39% |
| 2019-09-30 | 7.14% |
| 2019-06-30 | 7.06% |
| 2019-03-31 | -0.29% |
| 2018-12-31 | -1.02% |
| 2018-09-30 | 8.50% |
| 2018-06-30 | 8.44% |
| 2018-03-31 | 17.24% |
| 2017-12-31 | 17.57% |
| 2017-09-30 | 14.46% |
| 2017-06-30 | 15.51% |
| 2017-03-31 | 15.14% |
| 2016-12-31 | 14.44% |
| 2016-09-30 | 14.21% |
| 2016-06-30 | 13.85% |
| 2016-03-31 | 14.33% |
| 2015-12-31 | 14.08% |
| 2015-09-30 | 13.61% |
| 2015-06-30 | 12.83% |
| 2015-03-31 | 12.80% |
| 2014-12-31 | 12.23% |
| 2014-09-30 | 12.03% |
| 2014-06-30 | 12.81% |
| 2014-03-31 | 12.47% |
| 2013-12-31 | 12.09% |
| 2013-09-30 | 11.56% |
| 2013-06-30 | 10.83% |
| 2013-03-31 | 10.61% |
| 2012-12-31 | 10.30% |
| 2012-09-30 | 10.33% |
| 2012-06-30 | 9.69% |
| 2012-03-31 | 9.26% |
| 2011-12-31 | 9.10% |
| 2011-09-30 | 9.13% |
| 2011-06-30 | 8.80% |
| 2011-03-31 | 8.88% |
| 2010-12-31 | 9.09% |
| 2010-09-30 | 9.42% |
| 2010-06-30 | 10.21% |
| 2010-03-31 | 10.44% |
| 2009-12-31 | 10.33% |
| 2009-09-30 | 10.08% |
| 2009-06-30 | 9.16% |
| 2009-03-31 | 9.07% |
| 2008-12-31 | 9.29% |
| 2008-09-27 | 9.11% |
| 2008-06-28 | 9.17% |
| 2008-03-29 | 9.26% |
| 2007-12-31 | 8.42% |
| 2007-09-29 | 6.83% |
| 2007-06-30 | 5.73% |
| 2007-03-31 | 4.26% |
| 2006-12-31 | 13.80% |
| 2006-09-30 | 14.40% |
| 2006-07-01 | 14.61% |
| 2006-04-01 | 14.50% |
| 2005-12-31 | 14.70% |
| 2005-10-01 | 13.49% |
| 2005-07-02 | 13.09% |
| 2005-04-02 | 13.02% |
| 2004-12-31 | 13.15% |
| 2004-10-02 | 13.81% |
| 2004-07-03 | 14.25% |
| 2004-04-03 | 14.26% |
| 2003-12-31 | 14.07% |
| 2003-09-27 | 13.65% |
| 2003-06-28 | 13.67% |
